Inhibikase Therapeutics Inc (IKT): Market Valuation

Inhibikase (IKT) - corporate logo

The Inhibikase Therapeutics (IKT) price visualization on the GURU.Markets platform reflects the asset's dynamics, with a current value of 0.20. Anticipation regarding the results of Phase II trials for its Parkinson's disease treatment is fueling trader excitement. The business model relies on developing long-term medications protected by a robust patent shield, while therapy reliability is ensured through complex temperature-controlled logistics, which increases delivery costs.

IKT inhibikase.com: Market Capitalization in the range 07/04/2022 - 11/17/2026

Metric breakdowns and analytics for inhibikase.com (IKT)

Summary company analysis:IKT (inhibikase.com)
Manufactured products of Inhibikase Therapeutics

The biotech sector is often subject to sharp volatility due to regulatory risks, yet the independence of the Inhibikase Therapeutics (IKT) product cycle from macroeconomic factors creates a significant margin of safety. The company's market capitalization dynamics reflect the current market consensus regarding the value of all business shares. Analyzing this market capitalization allows for the identification of asset overvaluation and the precise calculation of an M&A premium, which protects investor capital from unjustified price spikes.

Competitor analysis

Market Capitalization BIIB (Biogen Idec)|Neurocrine Biosciences Inc - Market Value|regencellbioscience.com - Market Capitalization|Market Capitalization axsome.com AXSM|ACAD: Market Capitalization|Market Value Xenon Pharmaceuticals Inc. (XENE)|Market Value Viking Therapeutics|Market Capitalization SUPN (Supernus Pharma)|Market Capitalization CPRX|DNLI - Market Value|harmonybiosciences.com - Market Valuation|Market Capitalization Biohaven Ltd BHVN|AMLX - Market Value|Market Value TRVI (Trevi Corp)|Praxis Precision Medicines Inc (PRAX) - Market Value|Market Value Anavex Life Sciences (AVXL)|CBLL (CeriBell Inc) - Market Capitalization|Prothena Corporation - Market Valuation|Market Value Alector (ALEC)|Annexon Biosciences Inc. - Market Capitalization|Market Capitalization OMER (Omeros)|Market Capitalization neurogene.com NGNE|AC Immune S.A. - Market Capitalization|VYGR - Market Capitalization|neumoratx.com (NMRA) - Market Value|Market Value Scilex Holding Company (SCLX)|TVGN (Tevogen Bio Holdings Inc.) - Market Capitalization|ACOG: Market Value|Market Capitalization CGTX|Market Capitalization Cassava (SAVA)|Market Value Assertio ASRT|Coya Therapeutics, Inc. (COYA) - Market Value|VTGN: Market Valuation|Market Value OVID (ovidrx.com)|ABOS: Market Capitalization|CRVO - Market Capitalization|ATHE (alteritytherapeutics.com) - Market Capitalization|Market Valuation clene.com (CLNN)|Market Value pepgen.com (PEPG)|JUNS (Jupiter Neurosciences, Inc.) - Market Value|Market Capitalization RLMD (relmada.com)|Market Capitalization Annovis Bio Inc (ANVS)|GRCE: Market Valuation|Market Capitalization Firefly Neuroscience Inc AIFF|KLTO: Market Capitalization|NeuroSense Therapeutics Ltd - Market Value|Market Valuation RVPH|Market Capitalization MTVA (MetaVia Inc)|Market Value NeurAxis Inc (NRXS)|Helius Medical Technologies Inc. - Market Capitalization|Market Capitalization PASG (Passage Bio Inc.)|Market Capitalization bionomics.com.au NEUP|Minerva Neurosciences Inc - Market Capitalization|ATHA - Market Capitalization|ADXN: Market Capitalization|Alzamend (ALZN) - Market Capitalization|CYCN (cyclerion.com) - Market Capitalization|Protagenic Therapeutics (PTIX) - Market Capitalization|Market Value pasitheaclinics.com (KTTA)|CRGT (Cortigent Inc) - Market Value|Market Capitalization ATXI (Avenue Therapeutics Inc)|Market Value BCLI|Cara Therapeutics Inc - Market Capitalization|Chromocell Therapeutics (CHRO) - Market Valuation|ELYM (Eliem Therapeutics Inc.) - Market Valuation|ITCI - Market Capitalization|Market Value Longboard Pharma|Market Capitalization MRNS (Marinus Pharma)|Market Value NKGen Biotech Inc (NKGN)|NRBO - Market Value|Market Capitalization SAGE (Sage Therapeutics Inc)|Synaptogenix Inc. (SNPX) - Market Value|TRVN: Market Valuation|Market Capitalization vigilneuro.com VIGL|WENA (Anew Medical Inc.) - Market Valuation|Market Valuation Cerevel Therapeutics